Skip to content

Insider · CIK 0001959756

Jane Elizabeth Keyser

director

Files at NRXS (Neuraxis, INC). First filing -, latest -.

Jane Elizabeth Keyser files SEC Form 4 as director at NRXS (Neuraxis, INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Jane Elizabeth Keyser has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 22, 2026NRXS
Neuraxis, INC
AGrant or award
Common Stock
+21,598$4.63$100k46,335Feb 26, 2026
Jan 17, 2025NRXS
Neuraxis, INC
AGrant or award
Common Stock
+13,157$2.85$37k24,737Sep 10, 2025

Questions about Jane Elizabeth Keyser

Answered from the filings on this page, as of the latest one.

Is Jane Elizabeth Keyser buying or selling?

Jane Elizabeth Keyser has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Jane Elizabeth Keyser's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jane Elizabeth Keyser has 0.

Where does Jane Elizabeth Keyser file Form 4?

Jane Elizabeth Keyser has filed Form 4 at NRXS (Neuraxis, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.